Let's look at some numbers, Jackpot. As I posted, on January 7,...

Let's look at some numbers, Jackpot.

As I posted, on January 7, 2019, Omron Healthcare CEO Ranndy Kellogg unveiled the world’s first wearable blood pressure monitor…and a strategic move into health coaching.

"There are 103 million hypertensive Americans", Kellogg said.

"This year, Omron Healthcare will offer a range of devices tailored to serve every one of them."

CardieX CEO Craig Cooper may soon be able to say much the same thing.

Omron and CardieX will share the US market. And other key markets.

As I also posted, Omron claims to have sold 200m BP units in 40 years.

This is a remarkable figure. It means the Japanese group has sold an average of 5m a year.

Omron's a private group. I gather it doesn't publish detailed sales data.

But supposing it sold last year 10m BP units at an average of $100 per unit. That's a total of $1b.

If CardieX was to develop equivalent consumer devices, a 10% market share would deliver gross sales of $100m.

Add licensing fees for its Central BP tech to be embedded in smart watches, income from it's 50/50 Blumio JV plus revenue from on-going subscription fees from its insurance-related health coaching business and we can see that CardieX could grow from being a $37m MC minnow to being a $1b MC unicorn.